PREdictive value of the Self-triagecard and Chlamydia trachomatis positivity rate in vocational School students (PRESS-study)

PREdictive value of the Self-triagecard and Chlamydia trachomatis positivity rate in vocational School students (PRESS-study) - PRESS-study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON31773

Enrollment

1400

Registered

2008-06-25

Start date

2008-10-27

Completion date

Unknown

Last updated

2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

seksueel overdraagbare aandoeningen: gonorroe Chlamydia trachomatis Neisseria Gonorrhoea STD venereal diseases

Interventions

The intervention is filling in a 7-item self-triagecard and obtaining testadvice accordingly.

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Vocational school student Age 18-29 years old

Exclusion criteria

Exclusion criteria: Younger than 18 years old

Design outcomes

Primary

Measure	Time frame
1. CT positivity rate (prevalence) in both groups (intervention group and control group) 2. Effectivity of the self-triagecard: Agreement between score of the self-triage card and CT positivity rate 3. Feasibility of the self-triagecard: Differences between the intervention and the control group in willingness to CT testing and the difference in the intended test uptake 4. CT serovar distribution of CT positive vocational school participants to identify networks.	—

Measure

Time frame

1. CT positivity rate (prevalence) in both groups (intervention group and control group) 2. Effectivity of the self-triagecard: Agreement between score of the self-triage card and CT positivity rate 3. Feasibility of the self-triagecard: Differences between the intervention and the control group in willingness to CT testing and the difference in the intended test uptake 4. CT serovar distribution of CT positive vocational school participants to identify networks.

—

Secondary

Measure	Time frame
GC prevalence in both groups	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)